EUVIMEDEUVIMED entdecken
Crossref

Which Combination is the Best? A Comparison of the Predictive Potential of Serum Biomarker Combinations to Diagnose Periprosthetic Joint Infection

Jonathan S Yu, Troy D Bornes, Mark P Youssef, Kathleen W Tam, Allina A Nocon, Peter K Sculco, Alberto V Carli

The Journal of Arthroplasty · 2023

DOI: 10.1016/j.arth.2023.05.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2023. Verfasst von Jonathan S Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Stavros Niarchos Complex Joint Reconstruction Center, Adult Reconstruction and Joint Replacement Service, Hospital for Special Surgery, New York, New…. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Arthritis, Infectious. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Without a gold-standard test, recent periprosthetic joint infections (PJI) literature has explored the utility of combining serological results, with promising findings. However, previous studies evaluated fewer than 200 patients and often studied only 1 to 2 test combinations. The purpose of this study was to accumulate a large single-institution cohort of revision total joint arthroplasty (rTJA) patients to determine the diagnostic utility of combination serum biomarkers to identify PJI. METHODS: A single institution longitudinal database was assessed to identify all patients who underwent rTJA from 2017 to 2020. There were 1,363 rTJA patients (715 rTKA patients and 648 rTHA patients) including 273 PJI cases (20%) analyzed. The PJI was diagnosed post-rTJA utilizing 2011 Musculoskeletal Infection Society (MSIS) criteria. Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), D-dimer, and interleukin 6 (IL-6) were systematically collected for all patients. RESULTS: The rTKA combination markers of CRP + ESR (sensitivity: 78.3%, specificity: 88.8%, positive predictive value (PPV): 70.0%, negative predictive value (NPV): 92.5%), CRP + D-dimer (sensitivity: 60.5%, specificity: 92.6%, PPV: 63.4%, NPV: 91.7%), and CRP + IL-6 (sensitivity: 38.5%, specificity: 100.0%, PPV: 100.0%, NPV: 92.9%) all yielded higher specificity than CRP alone (sensitivity: 94.4%, specificity: 75.0%, PPV: 55.5%, NPV: 97.6%). Similarly, the rTHA combination markers of CRP + ESR (sensitivity: 70.1%, specificity: 88.8%, PPV: 58.1%, NPV: 93.1%), CRP + D-dimer (sensitivity: 57.1%, specificity: 90.1%, PPV: 43.2%, NPV: 94.1%), and CRP + IL-6 (sensitivity: 21.4%, specificity: 98.4%, PPV: 60.0%, NPV: 91.7%) all yielded higher specificity than CRP alone (sensitivity: 84.7%, specificity: 77.5%, PPV: 45.4%, NPV: 95.8%). CONCLUSION: Overall, in diagnosing PJI for both rTKA and rTHA, 2-marker combinations yielded higher specificity, while 3-marker combinations yielded higher sensitivity compared to CRP alone. However, compared to all 2-marker and 3-marker combinations, CRP demonstrated superior overall diagnostic utility. These findings suggest that routine combination testing of markers for PJI diagnosis may be excessive and an unnecessary use of resources, especially in resource-limited situations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prosthesis-Related InfectionsArthroplasty, Replacement, HipArthroplasty, Replacement, KneeArthritis, InfectiousHumansInterleukin-6BiomarkersC-Reactive ProteinBlood SedimentationSensitivity and SpecificityRetrospective Studies

Stichwörter der Autor:innen

biomarkerscombination markersprosthetic joint infectiontotal hip arthroplastytotal knee arthroplasty

Substanzen

Interleukin-6BiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Stavros Niarchos Complex Joint Reconstruction Center, Adult Reconstruction and Joint Replacement Service, Hospital for Special Surgery, New York, New York; Department of Orthopaedic Surgery, UCLA, Los Angeles, Californi…
  • Stavros Niarchos Complex Joint Reconstruction Center, Adult Reconstruction and Joint Replacement Service, Hospital for Special Surgery, New York, New York.

Zitieren

APA

Yu, J. S., Bornes, T. D., Youssef, M. P., Tam, K. W., Nocon, A. A., Sculco, P. K., & Carli, A. V. (2023). Which Combination is the Best? A Comparison of the Predictive Potential of Serum Biomarker Combinations to Diagnose Periprosthetic Joint Infection. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2023.05.025

Vancouver

Yu JS, Bornes TD, Youssef MP, Tam KW, Nocon AA, Sculco PK, et al. Which Combination is the Best? A Comparison of the Predictive Potential of Serum Biomarker Combinations to Diagnose Periprosthetic Joint Infection. The Journal of Arthroplasty. 2023. doi:10.1016/j.arth.2023.05.025

BibTeX
@article{Yu2023,
  author = {Yu, Jonathan S and Bornes, Troy D and Youssef, Mark P and Tam, Kathleen W and Nocon, Allina A and Sculco, Peter K and Carli, Alberto V},
  title = {Which Combination is the Best? A Comparison of the Predictive Potential of Serum Biomarker Combinations to Diagnose Periprosthetic Joint Infection},
  journal = {The Journal of Arthroplasty},
  year = {2023},
  doi = {10.1016/j.arth.2023.05.025}
}
Kostenlos starten →